Mepolizumab-a novel option for the treatment of hypereosinophilic syndrome in childhood.

Schwarz, Carsten; Müller, Thilo; Lau, Susanne; Parasher, Kirn; Staab, Doris; Wahn, Ulrich

Schwarz, Carsten; Müller, Thilo; Lau, Susanne; Parasher, Kirn; Staab, Doris; Wahn, Ulrich.

Affiliation

Schwarz C; Department of pediatric Pneumology and Immunology, Charité-Universitaetsmedizin Berlin, Berlin, Germany.
Müller T; Department of pediatric Pneumology and Immunology, Charité-Universitaetsmedizin Berlin, Berlin, Germany.
Lau S; Department of pediatric Pneumology and Immunology, Charité-Universitaetsmedizin Berlin, Berlin, Germany.
Parasher K; Department of pediatric Pneumology and Immunology, Charité-Universitaetsmedizin Berlin, Berlin, Germany.
Staab D; Department of pediatric Pneumology and Immunology, Charité-Universitaetsmedizin Berlin, Berlin, Germany.
Wahn U; Department of pediatric Pneumology and Immunology, Charité-Universitaetsmedizin Berlin, Berlin, Germany.

Pediatr Allergy Immunol ; 29(1): 28-33, 2018 02.

Article in En | MEDLINE | ID: mdl-28986919

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Hypereosinophilic Syndrome/drug therapy; Interleukin-5/antagonists & inhibitors; Adolescent; Bronchoscopy/methods; Child; Female; Humans; Hypereosinophilic Syndrome/diagnosis; Leukocyte Count/methods; Male; Tomography, X-Ray Computed/methods; Treatment Outcome

Key words

anti-IL-5 antibodies; hypereosinophilic syndrome; mepolizumab

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Interleukin-5 / Hypereosinophilic Syndrome / Antibodies, Monoclonal, Humanized Type of study: Diagnostic_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Pediatr Allergy Immunol Journal subject: ALERGIA E IMUNOLOGIA / PEDIATRIA Year: 2018 Type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google